What Researchers Did
Researchers first developed safe hyperbaric oxygen therapy (HBOT) pressure settings in rabbits, then tested these settings on 127 patients with severe lung and chest infections.
What They Found
The study found that a short course of hyperbaric oxygen therapy, consisting of 4-5 sessions, was both safe and clinically effective for 127 patients suffering from acute lung and chest infections. The specific pressure regimens developed in animal experiments were successfully applied to human patients without causing lung barotrauma.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy could be a beneficial treatment for Canadian patients with severe lung and chest infections, especially those with widespread tissue damage and significant internal poisoning. The findings indicate that a brief course of 4-5 HBOT sessions may offer a safe and effective way to improve outcomes for these challenging conditions.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study, published in 1983, does not specify the exact hyperbaric oxygen therapy pressure or duration per session, and the abstract does not mention a comparative control group.